Noveris Health Sciences is trading at CA$0.04, up +12.50%, with no confirmed company-specific catalyst; a biotech-sector rally may be contributing.

  • No company-specific announcement was found for November 4; the latest company news in search results predates today.
  • XBI was reported up 2.13% during the regular session amid a broader sector rally, but available evidence does not establish a direct cause for Noveris Health Sciences’ gain.
  • Trading volume data was not available.